Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Operating Margin (2017 - 2022)

Acro Biomedical has reported Operating Margin over the past 6 years, most recently at 1092.75% for Q4 2022.

  • Quarterly results put Operating Margin at 1092.75% for Q4 2022, down 146473.0% from a year ago — trailing twelve months through Sep 2023 was 3533.57% (down 245031.0% YoY), and the annual figure for FY2022 was 2409.98%, down 227499.0%.
  • Operating Margin for Q4 2022 was 1092.75% at Acro Biomedical, up from 1316.11% in the prior quarter.
  • Over the last five years, Operating Margin for ACBM hit a ceiling of 7803.87% in Q3 2019 and a floor of 1316.11% in Q1 2022.
  • Median Operating Margin over the past 5 years was 0.98% (2018), compared with a mean of 461.39%.
  • Biggest five-year swings in Operating Margin: skyrocketed 779718bps in 2019 and later crashed -146473bps in 2022.
  • Acro Biomedical's Operating Margin stood at 6.96% in 2018, then tumbled by -460bps to 38.98% in 2019, then surged by 130bps to 11.85% in 2020, then surged by 3038bps to 371.98% in 2021, then plummeted by -394bps to 1092.75% in 2022.
  • The last three reported values for Operating Margin were 1092.75% (Q4 2022), 1316.11% (Q1 2022), and 371.98% (Q4 2021) per Business Quant data.